The H₂O₂ Advantage: Why Hydrogen Peroxide Is the Right Answer to the 2025 HLD Crisis
When 2025 validation studies confirmed that UV-C automated reprocessors don’t achieve sporicidal efficacy, one chemistry came out on top. Here’s why STERIS Revital-Ox RESERT and the R60 test strip are the gold standard for endocavitary probe high-level disinfection — backed by the science.
The 2025 AIUM guideline revision made something clear that has been true for years but rarely enforced: every endocavitary ultrasound probe — transvaginal, transrectal, transesophageal — requires mandatory high-level disinfection between every patient use. The Joint Commission made it a primary survey focus. The research literature documented HPV persistence at 2.5% on probes that had only received low-level disinfection. And when investigators put automated HLD devices to the test, UV-C systems failed to achieve the sporicidal efficacy benchmarks that define true HLD.
What passed? Hydrogen peroxide. Specifically, the category of oxidative HLD chemistry that STERIS has built into Revital-Ox RESERT High Level Disinfectant — a 2% hydrogen peroxide formulation that has been FDA-cleared, clinically validated, and manufacturer-approved for reprocessing the semi-critical devices your facility cannot afford to get wrong.
Why the Chemistry Matters
High-level disinfection is not a single category. It encompasses several chemistries — aldehydes (glutaraldehyde, OPA), oxidatives (hydrogen peroxide, peracetic acid), and emerging technologies including UV-C and chlorine dioxide — each with meaningfully different profiles for efficacy, safety, material compatibility, and practical use.
For decades, aldehyde-based HLDs dominated endoscope reprocessing. Glutaraldehyde and OPA became standard partly because they were what existed, and partly because they worked. But a growing body of research has documented their limitations: aldehydes fixate organic soils onto device surfaces, meaning that inadequate pre-cleaning is not just a procedural failure — it’s a permanent contamination hazard that the disinfectant itself makes worse. Aldehyde-based HLDs also require multiple rinse cycles, generate fumes that require ventilation, and have documented cases of microbial resistance in certain nontuberculous mycobacteria.
Revital-Ox RESERT belongs to the oxidative chemistry category — a fundamentally different mechanism that does not fixate organic soils, has no known microbial resistance, requires only a single rinse, and generates no fumes requiring special ventilation under normal use conditions.
The Case Against Aldehydes — and Why H₂O₂ Replaced Them
If you’re still running glutaraldehyde or OPA in your endoscopy suite or ultrasound reprocessing area, you’re working with chemistry that the evidence has consistently found wanting on multiple fronts.
The soil fixation problem is arguably the most clinically significant. Aldehyde compounds chemically cross-link proteins — that’s partly why they’re effective disinfectants. But when organic material (blood, mucus, tissue debris) is present on a device surface that hasn’t been thoroughly pre-cleaned, those same aldehydes lock the contamination in place, creating a biofilm scaffold that subsequent cycles of disinfection cannot reliably penetrate. The Pineau 2008 study in the Journal of Hospital Infection compared fixative properties across five disinfectant solutions and found aldehyde-based HLDs significantly more likely to fix organic soils onto surfaces than oxidative chemistries.
The resistance issue compounds this. Burgess et al. in Infection Control & Hospital Epidemiology (2017) documented disinfectant susceptibility profiling of glutaraldehyde-resistant nontuberculous mycobacteria. Fisher et al. in the American Journal of Infection Control (2012) linked aldehyde-resistant mycobacteria to endoscope reprocessing system failures. No equivalent resistance has been documented for oxidative H₂O₂-based chemistries.
“Oxidative high-level disinfectants have no known resistance to microorganisms. Aldehyde-based HLDs have documented resistance in certain nontuberculous mycobacteria.”STERIS Revital-Ox RESERT Technical Data Monograph
Then there’s the operational burden. Multiple rinse cycles. Special ventilation requirements for glutaraldehyde. Documented contact dermatitis and respiratory complaints from OPA residues. These aren’t abstract safety concerns — they’re workflow barriers that contribute to protocol shortcuts and non-compliance, which ultimately hurt patients.
Revital-Ox RESERT requires no special ventilation under normal use conditions, has no documented patient contraindications, no contact dermatitis association, no respiratory distress concerns, and requires only a single one-minute rinse.
The R60 Test Strip: Compliance Built Into the Protocol
One of the more consequential failures in HLD programs is the use of solution that has degraded below its minimum recommended concentration (MRC) — without anyone knowing. Hydrogen peroxide is an unstable molecule. Over the 21-day reuse life of a container of Revital-Ox RESERT, the 2% nominal concentration naturally decays. The question isn’t whether it decays — it’s whether the concentration remains above the 1.5% MRC threshold at which HLD efficacy is validated.
That’s exactly what the Revital-Ox RESERT R60 Solution Test Strip answers. Before every single HLD cycle, the test strip is used to confirm that the hydrogen peroxide concentration remains at or above 1.5%. The test takes 62 seconds. The result is binary and unambiguous: pass (above MRC) or fail (below MRC, solution must be replaced).
Revital-Ox RESERT R60 Solution Test Strips
The R60 test strip is the mandatory verification step in the Revital-Ox RESERT protocol. It ensures that every HLD cycle is performed at a concentration validated to achieve high-level disinfection. This is the compliance piece — the documented proof that the solution was above MRC at the time of use.
Each test result should be logged on the VERDOC RESERT HLD Solutions Processing Log Form, documenting patient ID, date/time, exposure time, temperature, items processed, and test results — the written record TJC requires during survey.
TJC surveyors will ask for documentation of MRC testing before each HLD cycle. Verbal confirmation is not sufficient. The R60 strip result must be logged, time-stamped, and associated with the specific device processed. A facility running two cycles per day, five days per week, uses approximately 40 R60 strips per month.
What the 2025 Validation Study Found
When a 2025 study published on ScienceDirect evaluated the performance qualification of ultrasound probe HLD devices in clinical settings, the results divided the field. Hydrogen peroxide mist and vapor-based systems — the same oxidative chemistry category as Revital-Ox RESERT — demonstrated consistent sporicidal efficacy. UV-C automated reprocessor devices failed to achieve sporicidal efficacy. They did not meet the threshold that defines true high-level disinfection.
A separate PMC study on optimizing ultrasound probe disinfection for HAI control found that hydrogen peroxide was the most effective disinfectant tested, achieving greater than a 5-log₁₀ reduction in viral load, including human papillomavirus — the specific pathogen that makes endocavitary probe HLD non-negotiable.
Hydrogen peroxide-based HLD systems demonstrated consistent sporicidal efficacy in 2025 clinical validation studies, achieving >5-log₁₀ viral load reduction including against HPV strains found on inadequately reprocessed endocavitary probes.
UV-C automated systems did not meet sporicidal efficacy benchmarks in the same study period. Facilities relying on UV-C devices for endocavitary probe HLD should verify compliance status and consider transitioning to a validated H₂O₂ or chlorine dioxide-based protocol.
The Complete Revital-Ox RESERT HLD Protocol
Pre-Clean the Probe Immediately After Patient Use Critical
Remove gross contamination and pre-clean at point of use before transport to the reprocessing area. Revital-Ox RESERT does not fixate organic soils like aldehyde HLDs — but thorough cleaning is still the prerequisite for effective HLD.
Test the Solution with an R60 Strip Before Every Cycle R60 Required
Before immersing any device, dip an R60 strip into the solution and read the result at 62 seconds. If the strip confirms ≥1.5% H₂O₂ (MRC), proceed. If not, the solution must be replaced before the cycle begins. Log the result immediately.
Immerse the Probe for a Minimum of 8 Minutes at ≥20°C 8 Min
Fully immerse the cleaned probe in Revital-Ox RESERT at a minimum temperature of 20°C (68°F) for a minimum of 8 minutes. Ensure all surfaces, lumens, and channels are in contact with the solution. Document the immersion time, temperature, and solution lot number.
Rinse with Sterile or Filtered Water for a Minimum of 1 Minute Required
Rinse thoroughly for a minimum of one minute (or longer per the probe manufacturer’s instructions). Only one rinse cycle is needed — a significant workflow advantage over aldehyde-based HLDs that require multiple rinses.
Dry and Store the Probe Appropriately Required
Thoroughly dry the probe before storage. Moisture left in lumens or on surfaces supports microbial growth and negates the HLD cycle. Store reprocessed probes in a closed cabinet, hanging vertically, protected from recontamination.
Document the Complete Cycle on a VERDOC RESERT HLD Log Form TJC Required
Every HLD cycle must be documented: patient ID, date and time, exposure time, temperature, probe identification, R60 test result, and operator. The VERDOC RESERT HLD Solutions Processing Log Form records 22 cycles per double-sided form.
Revital-Ox RESERT High Level Disinfectant — 1L
FDA-cleared hydrogen peroxide HLD for manual soaking and open-architecture automated reprocessors. Compatible with ultrasound probes and flexible endoscopes. Verify your specific device at the STERIS Device Compatibility Matrix.
Manufacturer Compatibility — Broad Device Coverage
STERIS maintains an official Device Compatibility Matrix for Revital-Ox RESERT listing semi-critical medical devices tested to confirm materials compatibility. Major ultrasound probe manufacturers including Philips and Siemens have approved Revital-Ox RESERT for use with a majority of their probe lines.
After opening, the solution may be stored for use for up to 90 days (provided this does not extend past the expiration date). When poured into a secondary container for soaking, the 21-day reuse clock begins — monitored with an R60 strip before each cycle.
The product has an 18-month shelf life and requires no special venting during use or storage. Biodegradable ingredients. No detoxification or deactivation processes required for disposal under normal use conditions.
The Right HLD Solution. The Compliance Strip to Match.
Revital-Ox RESERT and the R60 test strips are the complete HLD system for endocavitary probe reprocessing — science-backed, TJC-compliant, and available from SONO Supplies.
References
- STERIS Corporation. Revital-Ox RESERT HLD — Product Overview & Technical Data. steris.com
- STERIS Corporation. Revital-Ox RESERT R60 Solution Test Strip (PCC053). shop.steris.com
- ScienceDirect. Validation of Performance Qualification of Ultrasound Probe HLD Devices in Clinical Settings. 2025. sciencedirect.com
- PMC/NIH. Optimizing Ultrasound Probe Disinfection for HAI Control: Comparative Analysis of Disinfectant Efficacy. 2024. ncbi.nlm.nih.gov
- AIUM. Guidelines for Cleaning and Preparing Ultrasound Transducers — 2025 Revision. aium.org
- Burgess W, et al. Disinfectant Susceptibility Profiling of Glutaraldehyde-Resistant Nontuberculous Mycobacteria. Infection Control & Hospital Epidemiology. 2017.
- Fisher W, et al. Aldehyde-Resistant Mycobacteria Associated with Endoscope Reprocessing Systems. American Journal of Infection Control. 2012.
- Pineau L, et al. Comparison of Fixative Properties of Five Disinfectant Solutions. Journal of Hospital Infection. 2008.
- PMC/NIH. Persistence of Microbial Contamination on Transvaginal Ultrasound Probes despite LLD. PLOS ONE. ncbi.nlm.nih.gov
- SONO Supplies. STERIS Revital-Ox RESERT HLD & R60 Test Strips. sonosupplies.com
